The impact of the COVID-19 pandemic on infertility patients and endometriosis patients in the Netherlands

Rosielle, K.; Bergwerff, Jasmijn; Schreurs, A M F; Knijnenburg, J.M.L.; Bie, Bianca De; Maas, Jacques W.M.; Nap, Annemiek W.; Wely, Madelon van; Lambalk, Cornelis B.; Goddijn, Mariëtte; Custers, Inge M.; Loendersloot, L.L. van; Mijatovic, Velja

doi:10.1016/j.rbmo.2021.06.001

Cited by 19 publications

(18 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Several studies have shown that the pandemic has contributed to a worsening of the quality of life in patients with endometriosis 35 , 36 , 37 , 38 ; however, there is a lack of reliable data on whether or not patients with endometriosis have an increased risk of developing COVID‐19 disease or if they experience a more severe infection.…”

Section: Discussionmentioning

confidence: 99%

“…Several studies have shown that the pandemic has contributed to a worsening of the quality of life in patients with endometriosis [35][36][37][38] ; however, there is a lack of reliable data on whether or not patients with The study conducted by Moazzami et al 24 evaluated the risk of acquiring COVID-19 disease in 507 women with endometriosis versus 520 without endometriosis attending the Tehran hospital from May to July 2020. This study highlighted that SARS-CoV-2 infection rates among the two groups of women were of 3.2% and 3%, respectively, with no statistically significant difference between them.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

COVID‐19 susceptibility in endometriosis patients: A case control study

Savasta

Pietropaolo

Barbasetti

et al. 2022

American J Rep Immunol

View full text Add to dashboard Cite

Problem Starting from November 2019, the world has had to face a devastating pandemic caused by SARS‐CoV‐2. Various studies have identified potential risk factors facilitating the infection, however it has not been demonstrated whether endometriosis might represent one of them. The purpose of this study was to evaluate if patients with endometriosis had a higher risk of contracting COVID‐19 infection and, in such case, whether they developed a more severe infection than the general population. Furthermore, this study evaluated the possible correlation with the stage of endometriosis, based on the r‐ASRM score, and the potential worsening of the disease during the SARS‐CoV‐2 infection. Method of study A case‐control study was conducted from March 2020 to April 2021 at Macedonio Melloni Hospital, in Milan. A total of 401 women were recruited. The cases were 201 women with clinical or surgical diagnosis of endometriosis. The control group consisted of 200 women, without the disease. All women completed a self‐administered questionnaire which evaluated their demographic and clinical characteristics, as well as a potential diagnosis of Covid‐19. Results Comparison between the two groups showed that women with endometriosis had a higher frequency of COVID‐19 than the control subjects (23% vs. 13.5%, P = .014), with a greater prevalence of fever (14.4% vs. 6%, P = .008) and myalgias or arthralgias (11.4% vs. 4.5%, P = .01). In multivariable logistic regression analyses, women with endometriosis had a higher risk of contracting SARS‐CoV‐2 infection (OR = 2.11, 95% IC: 1.20–3.80), regardless the stage of the disease. Conclusion Endometriosis increases the susceptibility to COVID‐19, and women who suffer from it should be considered as fragile patients, worthy of prior access to SARS‐CoV‐2 vaccination campaign.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

COVID‐19 susceptibility in endometriosis patients: A case control study

Savasta

Pietropaolo

Barbasetti

et al. 2022

American J Rep Immunol

View full text Add to dashboard Cite

show abstract

“…Women with endometriosis showed an increase in social and emotional vulnerability during the COVID-19 pandemic [ 13 ]. A study conducted in the Netherlands reported an increase in endometriosis-related complaints by more than 80% of women with endometriosis during the pandemic [ 36 ]. Similar results were found in a group of Spanish women with endometriosis [ 37 ], and a cross-sectional international study conducted by Ashkenazi et al reported aggravation of symptoms in 35% of study participants [ 38 ].…”

Section: Introductionmentioning

confidence: 99%

“…As a result of the pandemic, a significant increase in mental health concerns, such as anxiety, depression, and lower resilience were observed in study populations worldwide [ 39 , 40 , 41 , 42 , 43 ]. Women diagnosed with endometriosis were at a high risk for developing mental health disorders, and their burden of psychological symptoms was greater with respect to mental health than the burden of the normative populations [ 19 , 36 , 38 , 44 ].…”

Section: Introductionmentioning

confidence: 99%

Determinants of Pain-Induced Disability in German Women with Endometriosis during the COVID-19 Pandemic

Schwab

Stewen

Kottmann³

et al. 2022

IJERPH

View full text Add to dashboard Cite

(1) Background: The main aim of this research was to examine the factors leading to pain-induced disability by assessing the impact of demographic, endometriosis-specific, pandemic-specific, and mental health factors. (2) Methods: Women with endometriosis who attended online support groups were invited to respond to an online survey during the first wave of the COVID-19 pandemic in Germany. The Pain Disability Index (PDI) was employed to assess disability-related daily functioning. Independent predictors of pain-induced disability were determined using univariate and multivariate logistic regression analyses. (3) Results: The mean PDI score of the study population was 31.61 (SD = 15.82), which was significantly higher (p < 0.001) than that reported in a previously published normative study of the German population. In the present study, a high level of pain-induced disability, as defined by scores equal to or higher than the median of the study population, older age (OR 1.063, 95% CI 1.010–1.120, p = 0.020), dysmenorrhea (OR 1.015, 95% CI 1.005–1.026, p = 0.005), dysuria (OR 1.014; 95% CI 1.001–1.027, p = 0.029), lower back pain (OR 1.018, 95% CI 1.007–1.029, p = 0.001), and impaired mental health (OR 1.271, 95% CI 1.134–1.425, p < 0.001) were found to be independent risk factors. Pandemic-specific factors did not significantly influence the pain-induced disability of the participants in this study. (4) Conclusions: The level of pain-induced disability was significantly higher among the women with endometriosis than among women in the normative German validation study. Our findings identified risk factors for experiencing a high level of pain-induced disability, such as demographic and specific pain characteristics. Pandemic-specific factors did not significantly and independently influence the pain-induced disability during the first wave of the COVID-19 pandemic in Germany. Impaired mental health negatively influenced functioning during daily activities. Thus, women with endometriosis should be managed by a multidisciplinary team of healthcare professionals to prevent negative effects of pain-induced disability on their quality of life.

show abstract

“…Furthermore, eHealth programs tried to ll this gap of direct interaction for example with online consultations. It was shown that they can provide a reasonable alternative [19].…”

Section: Introductionmentioning

confidence: 99%

Trends among patients with endometriosis over a 7-year period and the impact of the COVID-19 pandemic. Experience from an academic high level endometriosis centre in Germany.

Keilmann¹,

Beyer²,

Meister³

et al. 2022

Preprint

View full text Add to dashboard Cite

PurposeEndometriosis is known to be an underestimated disease. Lately the awareness of the disease seems to have improved. Aim of this analysis is to provide an overview of the development of treatment of patients diagnosed with endometriosis. This includes a special scope on implications of the COVID-19 pandemic since in multiple settings postponed treatments resulting in negative impact on prognosis were reported. Material and MethodsWe analysed the development of numbers of patients treated for endometriosis in an academic centre within a 7 year-period, 01/2015-12/2021, performing a systematic analysis of ICD-10-Codes from our computer system used in clinical routine.Results Treatment numbers increased over the past 7 years, i.e. 239 treated cases in 2015 vs. 679 in 2021.Following restrictions for outpatient evaluation and surgical capacity at our centre during COVID-19 pandemic the numbers of treated patients were reduced, especially in the first lockdown period. The comparison of 2020 to 2019 showed a reduction in April 2020 of -37 % in outpatient department and up to -90% for surgically treated patients. Comparing to 2019, we found a reduction of surgical interventions in 2020 by -9 % and an increase by 83% in 2021.ConclusionRaising numbers of patients treated for endometriosis point to a new awareness for the disease. After the decline during the lockdown period numbers raised again, leading to a delay, but not an omission of treatment. A certified endometriosis centre with established and well-organized structures is required to improve not only treatment results but also quality of life of those affected.

show abstract

The impact of the COVID-19 pandemic on infertility patients and endometriosis patients in the Netherlands

Abstract: The impact of the COVID-19 pandemic on infertility and endometriosis patients in the Netherlands: The use of virtual care, quality of life and patient-centeredness,

Cited by 19 publications

References 20 publications

COVID‐19 susceptibility in endometriosis patients: A case control study

COVID‐19 susceptibility in endometriosis patients: A case control study

Determinants of Pain-Induced Disability in German Women with Endometriosis during the COVID-19 Pandemic

Trends among patients with endometriosis over a 7-year period and the impact of the COVID-19 pandemic. Experience from an academic high level endometriosis centre in Germany.

Contact Info

Product

Resources

About